These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18181043)

  • 1. The growth-inhibitory effects of dexamethasone on renal cell carcinoma in vivo and in vitro.
    Arai Y; Nonomura N; Nakai Y; Nishimura K; Oka D; Shiba M; Nakayama M; Takayama H; Mizutani Y; Miki T; Okuyama A
    Cancer Invest; 2008 Feb; 26(1):35-40. PubMed ID: 18181043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids.
    Iwai A; Fujii Y; Kawakami S; Takazawa R; Kageyama Y; Yoshida MA; Kihara K
    Mol Cell Endocrinol; 2004 Oct; 226(1-2):11-7. PubMed ID: 15489000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
    Harada K; Supriatno ; Yoshida H; Sato M
    Int J Oncol; 2005 Dec; 27(6):1489-97. PubMed ID: 16273203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of nuclear factor kappa B attenuates tumour progression in an animal model of renal cell carcinoma.
    Morais C; Healy H; Johnson DW; Gobe G
    Nephrol Dial Transplant; 2010 May; 25(5):1462-74. PubMed ID: 20037166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells.
    Yano A; Fujii Y; Iwai A; Kageyama Y; Kihara K
    Clin Cancer Res; 2006 May; 12(10):3003-9. PubMed ID: 16707595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines.
    Morais C; Pat B; Gobe G; Johnson DW; Healy H
    Nephrol Dial Transplant; 2006 Dec; 21(12):3377-88. PubMed ID: 16998220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma.
    Kato Y; Yoshimura K; Shin T; Verheul H; Hammers H; Sanni TB; Salumbides BC; Van Erp K; Schulick R; Pili R
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4538-46. PubMed ID: 17671140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combined valproic acid and the epidermal growth factor/vascular endothelial growth factor receptor tyrosine kinase inhibitor AEE788 on renal cell carcinoma cell lines in vitro.
    Juengel E; Engler J; Mickuckyte A; Jones J; Hudak L; Jonas D; Blaheta RA
    BJU Int; 2010 Feb; 105(4):549-57. PubMed ID: 19594733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A third-generation bisphosphonate, minodronic acid (YM529), augments the interferon alpha/beta-mediated inhibition of renal cell cancer cell growth both in vitro and in vivo.
    Yuasa T; Nogawa M; Kimura S; Yokota A; Sato K; Segawa H; Kuroda J; Maekawa T
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):853-9. PubMed ID: 15701876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone as a chemosensitizer for breast cancer chemotherapy: potentiation of the antitumor activity of adriamycin, modulation of cytokine expression, and pharmacokinetics.
    Wang H; Wang Y; Rayburn ER; Hill DL; Rinehart JJ; Zhang R
    Int J Oncol; 2007 Apr; 30(4):947-53. PubMed ID: 17332934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effect of parathyroid hormone-related protein neutralizing antibody in human renal cell carcinoma in vitro and in vivo.
    Talon I; Lindner V; Sourbier C; Schordan E; Rothhut S; Barthelmebs M; Lang H; Helwig JJ; Massfelder T
    Carcinogenesis; 2006 Jan; 27(1):73-83. PubMed ID: 16081513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products.
    Kunnumakkara AB; Diagaradjane P; Guha S; Deorukhkar A; Shentu S; Aggarwal BB; Krishnan S
    Clin Cancer Res; 2008 Apr; 14(7):2128-36. PubMed ID: 18381954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB.
    Oka D; Nishimura K; Shiba M; Nakai Y; Arai Y; Nakayama M; Takayama H; Inoue H; Okuyama A; Nonomura N
    Int J Cancer; 2007 Jun; 120(12):2576-81. PubMed ID: 17290398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines.
    Grepin R; Guyot M; Jacquin M; Durivault J; Chamorey E; Sudaka A; Serdjebi C; Lacarelle B; Scoazec JY; Negrier S; Simonnet H; Pages G
    Oncogene; 2012 Mar; 31(13):1683-94. PubMed ID: 21909141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptors for luteinizing hormone releasing hormone expressed on human renal cell carcinomas can be used for targeted chemotherapy with cytotoxic luteinizing hormone releasing hormone analogues.
    Keller G; Schally AV; Gaiser T; Nagy A; Baker B; Halmos G; Engel JB
    Clin Cancer Res; 2005 Aug; 11(15):5549-57. PubMed ID: 16061872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted therapy of experimental renal cell carcinoma with a novel conjugate of monoclonal antibody 138H11 and calicheamicin thetaI1.
    Knoll K; Wrasidlo W; Scherberich JE; Gaedicke G; Fischer P
    Cancer Res; 2000 Nov; 60(21):6089-94. PubMed ID: 11085532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibitor of fatty acid synthase suppresses growth and invasiveness of renal cancer cells.
    Horiguchi A; Asano T; Asano T; Ito K; Sumitomo M; Hayakawa M
    J Urol; 2008 Aug; 180(2):729-36. PubMed ID: 18555493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of interleukin 6 and 8 production in head and neck cancer cells with curcumin via inhibition of Ikappa beta kinase.
    Cohen AN; Veena MS; Srivatsan ES; Wang MB
    Arch Otolaryngol Head Neck Surg; 2009 Feb; 135(2):190-7. PubMed ID: 19221248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.